Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival.
Dispinseri S, Secchi M, Pirillo MF, Tolazzi M, Borghi M, Brigatti C, De Angelis ML, Baratella M, Bazzigaluppi E, Venturi G, Sironi F, Canitano A, Marzinotto I, Tresoldi C, Ciceri F, Piemonti L, Negri D, Cara A, Lampasona V, Scarlatti G.
Dispinseri S, et al. Among authors: brigatti c.
Nat Commun. 2021 May 11;12(1):2670. doi: 10.1038/s41467-021-22958-8.
Nat Commun. 2021.
PMID: 33976165
Free PMC article.